Raymond James Financial Services Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$235K Buy
+3,273
New +$231K ﹤0.01% 3083
2024
Q2
Sell
-3,329
Closed -$267K 3430
2024
Q1
$267K Buy
3,329
+157
+5% +$14K ﹤0.01% 2914
2023
Q4
$347K Buy
3,172
+77
+2% +$7.96K ﹤0.01% 2645
2023
Q3
$312K Buy
3,095
+140
+5% +$16.1K ﹤0.01% 2626
2023
Q2
$402K Buy
2,955
+6
+0.2% +$732 ﹤0.01% 2480
2023
Q1
$306K Sell
2,949
-102
-3% -$9.86K ﹤0.01% 2633
2022
Q4
$270K Hold
3,051
﹤0.01% 2664
2022
Q3
$245K Sell
3,051
-46
-1% -$4.34K ﹤0.01% 2720
2022
Q2
$297K Sell
3,097
-11
-0.4% -$1.32K ﹤0.01% 2600
2022
Q1
$462K Buy
3,108
+118
+4% +$16.5K ﹤0.01% 2432
2021
Q4
$424K Sell
2,990
-26
-0.9% -$3.68K ﹤0.01% 2481
2021
Q3
$395K Buy
3,016
+104
+4% +$13.6K ﹤0.01% 2510
2021
Q2
$400K Buy
2,912
+154
+6% +$21.1K ﹤0.01% 2524
2021
Q1
$360K Sell
2,758
-94
-3% -$11.3K ﹤0.01% 2507
2020
Q4
$319K Buy
+2,852
New +$270K ﹤0.01% 2423

Other funds holding CNMD

Raymond James Financial Services Advisors's CNMD Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in CONMED (CNMD) in Q3 2024: 3,273 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #3083 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in CNMD as recently as Q1 2024.

Raymond James Financial Services Advisors first reported a position in CNMD in Q4 2020 and has held it in 15 quarters since. The position peaked at $462K in Q1 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Raymond James Financial Services Advisors held 3,273 shares of CONMED worth $235K as of Q3 2024.
  • CONMED was a new Raymond James Financial Services Advisors position in Q3 2024.
  • CONMED made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3083 holding.
  • Raymond James Financial Services Advisors first reported a position in CONMED in Q4 2020 and has held it in 15 quarters since.
  • Raymond James Financial Services Advisors's CONMED position peaked at $462K in Q1 2022.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.